Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, et al
What if someone prefers to use an alternate sublingual-suspension vehicle
[2] During a monotherapy clinical trial of topiramate in the treatment of epilepsy in adults, chest pain (unspecified) was reported in 1% of patients receiving 50 mg/day and 2% of patients receiving 400 mg/day
Note: GLP-1 medications carry a boxed warning regarding the risk of thyroid C-cell tumors based on animal studies
The findings confirmed significant lean mass reductions in larger trials, though they noted that body composition improvements were generally favorable when looking at fat-to-lean ratios
Simultaneously, sympathetic nervous system activity measured by HR variability and the rate-pressure-product were also elevated, and increases in HR, systolic BP and sympathetic nervous system activity were still observed even with a concomitant L-NMMA-infusion [38]